ALLR
NASDAQ
$1.17
Allarity Therapeutics Inc (ALLR)
Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $10.25 (+776.07%)
Market Cap
$19M
Free Cash Flow Yield
-89.46%
Price Chart
Valuation
Market Cap$19M
P/S53.04
P/B2.71
Profitability
Total Revenue (TTM)$345K
Gross Profit (TTM)$345K
EBITDA-$11M
Operating Margin-10752%
EPS-$0.72
Financial Health
Debt-to-Equity290.2%
Free Cash Flow Yield-89.46%
Growth & Risk
Sharpe Ratio0.57